Skip to main
ALAB
ALAB logo

ALAB Stock Forecast & Price Target

ALAB Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 41%
Buy 41%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Astera Labs Inc has demonstrated substantial revenue growth and strong gross margins, primarily driven by the accelerated demand for AI infrastructure and increased server shipments, which exceed initial expectations. The company's PCIe Gen 6 products significantly contributed over 20% to revenue in the third quarter, showcasing robust demand for its semiconductor solutions across multiple generations. With guidance for the fourth quarter indicating revenue of $249.0 million, reflecting an 8.0% quarter-over-quarter and 76.5% year-over-year increase, Astera Labs is poised for continued growth, supported by its industry-leading margins and expanding market opportunities in AI-driven platforms.

Bears say

Astera Labs Inc's revenue growth is closely tied to the pace of data center infrastructure spending, creating vulnerability to macroeconomic slowdowns that could negatively impact capital investment in the sector. The company's recent non-GAAP operating expenses (OpEx) for the quarter were reported at $70.7 million, which was lower than the estimated $74.0 million, potentially suggesting challenges in managing operational costs effectively. These factors, combined with market uncertainties, contribute to a negative outlook on the company's stock performance.

ALAB has been analyzed by 17 analysts, with a consensus rating of Buy. 41% of analysts recommend a Strong Buy, 41% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Astera Labs Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Astera Labs Inc (ALAB) Forecast

Analysts have given ALAB a Buy based on their latest research and market trends.

According to 17 analysts, ALAB has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $184.53, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $184.53, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Astera Labs Inc (ALAB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.